| Date Filed | Type | Description |
| 10/03/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 291 options to buy
@ $102.95, valued at
$30k
|
|
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/05/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 260 options to buy
@ $115.39, valued at
$30k
|
|
| 05/31/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/15/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/03/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 282 options to buy
@ $106.39, valued at
$30k
|
|
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/03/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 270 options to buy
@ $110.95, valued at
$30k
|
|
| 10/04/2022 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 348 options to buy
@ $86.12, valued at
$30k
|
|
| 08/12/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/01/2022 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 366 options to buy
@ $82.05, valued at
$30k
|
|
| 02/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/04/2022 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 391 options to buy
@ $76.64, valued at
$30k
|
|
| 11/01/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 2,478 options to buy
@ $80.72, valued at
$200k
|
|
| 04/02/2020 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 390 options to buy
@ $76.94, valued at
$30k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 2,336 options to buy
@ $79.21, valued at
$185k
|
|
| 04/02/2019 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 346 options to buy
@ $83.17, valued at
$28.7k
|
|
| 01/03/2019 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 376 options to buy
@ $76.41, valued at
$28.8k
|
|
|